alnylam pharmaceuticals inc
Ed Harlow Jr., Ph.D.
Former Member of the Scientific Advisory Board, Alnylam Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 12 board members in 1 different organizations across 3 different industries.|
See Board Relationships
Mr. Edward (Ed) E. Harlow, Jr. Ph.D., served as Chief Scientific Officer of Constellation Pharmaceuticals, Inc. from September 2009 to January 4, 2011. Dr. Harlow is a distinguished molecular biologist, is an internationally recognized leader in cancer biology who is best known for his discoveries regarding the control of cell division and critical changes that allow cancer to develop. He served at Cold Spring Harbor Laboratory from 1982 to 1990. He served as Scientific ...
300 Third StreetPhone: 617-551-8200
Cambridge, Massachusetts 02142
Board Members Memberships*There is no Board Members Memberships data available.
Unknown/Other Education 1982
University of Oklahoma
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Ali Mortazavi||Chief Executive and Director|
Silence Therapeutics plc
|Mark W. Schwartz Ph.D.||Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee|
Galena Biopharma, Inc.
|Mark Joseph Murray Ph.D.||Chief Executive Officer, President and Director|
Tekmira Pharmaceuticals Corporation
|Kleanthis G. Xanthopoulos Ph.D.||Chief Executive Officer, President, Principal Financial & Accounting Officer and Director|
Regulus Therapeutics Inc.
|$600.0K||Compensation as of Fiscal Year 2013.|